ROSCOVITINE(Seliciclib)

ROSCOVITINE(Seliciclib)

GW-9508

Catalog_noBDMC0043Product_nameGW-9508Category抑制剂与激动剂Size10mg/50mg/100mgPrice640.00/2660.00/4660.00SpecificityTarget: GPR40. Fields: GW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32.DilutionPurification98%Concentration靶点：GPR40;I

GW-9508

GW-9508

PF-299804

Catalog_noBDMC0044Product_namePF-299804 (Dacomitinib,PF-00299804)Category抑制剂与激动剂Size10mg/50mg/100mgPrice1340.00/2660.00/3880.00SpecificityTarget: EGFR. Fields: PF299804 is a potent, irreversible pan-ErbB inhibitor against ErbB1, ErbB2 and ErbB4 with IC50

PF-299804

PF-299804

Lorcaserin

Catalog_noBDMC0045Product_nameLorcaserinCategory抑制剂与激动剂Size10mg/50mg/100mgPrice2780.00/5000.00/8340.00SpecificityTarget: See reference. Fields: Lorcaserin (APD-356)is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties an

Lorcaserin

Lorcaserin

GSK-3787

Catalog_noBDMC0046Product_nameGSK-3787Category抑制剂与激动剂Size50mg/100mgPrice4180.00/7520.00SpecificityTarget: PPAR. Fields: GSK3787 is as a potent and selective antagonist of PPARδ with pIC50 of 6.6.DilutionPurification98%Concentration靶点：PPAR;IC50：No dataStor

GSK-3787

GSK-0660 (GSK0660)

Catalog_noBDMC0047Product_nameGSK-0660 (GSK0660)Category抑制剂与激动剂Size10mg/50mg/100mgPrice1100.00/4340.00/7780.00SpecificityTarget: PPAR. Fields: GSK-0660 is a selective PPARδ antagonist (IC50 values are 0.155,10 and ≥ 10 μM at PPARδ, PPARα and PPARγ respect

GSK-0660 (GSK0660)

GSK-0660 (GSK0660)

SU11274 (PKI-SU11274)

Catalog_noBDMC0048Product_nameSU11274 (PKI-SU11274)Category抑制剂与激动剂Size10mg/50mg/100mgPrice1720.00/6260.00/7940.00SpecificityTarget: c-Met/HGFR. Fields: SU11274 is a selective Met inhibitor with IC50 of 10 nM.DilutionIC50: 10 nM (Met)[1]Purification98%Conc

SU11274 (PKI-SU11274)

SU11274 (PKI-SU11274)

BMS754807

Catalog_noBDMC0049Product_nameBMS754807Category抑制剂与激动剂Size10mg/50mg/100mgPrice1120.00/4440.00/7220.00SpecificityTarget: IGF-1R. Fields: BMS-754807 is a potent and reversible inhibitor of IGF-1R/IR family kinases, inhibits IGF-1R, IR, Met, TrkA and TrkB wi